Hemp is a plant; CBD is a single chemical compound found inside that plant. Confusing them is a bit like confusing an orange with vitamin C. Hemp refers to varieties of Cannabis sativa grown with very low levels of THC (the compound that produces a high), while cannabidiol (CBD) is one of more than a hundred cannabinoids the cannabis plant produces. The two terms show up almost interchangeably on product labels, which is a big part of why the distinction gets blurry, but they describe fundamentally different things.
Hemp Is a Type of Cannabis Plant
Hemp and marijuana are both cannabis, but they were bred for very different purposes. Genomic research using thousands of genetic markers across hemp and marijuana samples has confirmed that the two are differentiated at a genome-wide level, not just in the genes responsible for THC production.1PubMed Central. The Genetic Structure of Marijuana and Hemp In practical and legal terms, hemp is cannabis that contains no more than 0.3% THC by dry weight. Anything above that threshold is classified as marijuana in most jurisdictions.
This split is not recent. Large-scale genomic analysis suggests that early domesticated cannabis was used as a multipurpose crop until roughly 4,000 years ago, when strong divergent selection pushed some lineages toward fiber production and others toward drug production.2PubMed Central. Large-scale whole-genome resequencing unravels the domestication history of Cannabis sativa The fiber-oriented lineages became what we now call hemp. These plants tend to be tall, thin-stalked, and grown in dense rows, while drug-type cannabis is bushier and cultivated for its resinous flowers.
CBD Is One Chemical Among Many
CBD is a specific molecule, one of the major cannabinoids produced by the cannabis plant. The plant synthesizes it through a biosynthetic pathway: an enzyme called CBDA synthase converts a precursor molecule (CBGA) into cannabidiolic acid (CBDA), which then loses a carbon dioxide group through heat or time to become CBD.3PubMed Central. Advancement of Research Progress on Synthesis Mechanism of Cannabidiol (CBD) The enzyme that makes THC (THCA synthase) is remarkably similar, sharing about 84% of its structure with the CBD-producing enzyme. The two enzymes act on the same precursor but fold it differently, producing either CBD or THC.
Both hemp and marijuana plants produce CBD, but hemp varieties have been bred to produce much more CBD relative to THC. That is why most commercial CBD products are derived from hemp: you get a CBD-rich extract without crossing the legal THC threshold. Still, CBD itself is not unique to hemp. Marijuana plants produce it too, sometimes in significant quantities.
Why Product Labels Make This Confusing
Walk through a health-food store and you will see “hemp oil,” “CBD oil,” “hemp extract,” and “hemp seed oil” sitting on the same shelf. These are not the same product, and the labels rarely make that clear.
- Hemp seed oil: Pressed from hemp seeds, which contain virtually no cannabinoids. It is a nutritional oil rich in omega fatty acids, used in cooking and skincare. It will not deliver any meaningful amount of CBD.
- CBD oil: An extract from the flowers and leaves of the hemp plant, concentrated to contain a significant dose of CBD. This is the product people typically mean when they talk about “taking CBD.”
- Hemp extract: A catch-all term that could mean either of the above, depending on the manufacturer. Some brands use it to mean a CBD-containing extract; others use it for a product that contains trace cannabinoids at best.
The ambiguity is not accidental. Regulatory uncertainty around CBD has led some companies to label their products as “hemp extract” to sidestep potential legal or advertising restrictions, even when CBD is the active ingredient they are selling. If a product does not list a specific milligram amount of CBD per serving, it may contain little to none.
Isolate, Broad-Spectrum, and Full-Spectrum Products
CBD products extracted from hemp come in three main formulations, and the differences matter more than most labels suggest. CBD isolate is pure cannabidiol with no other plant compounds. Broad-spectrum products contain CBD along with other terpenes and minor cannabinoids but have the THC removed. Full-spectrum products keep everything, including THC, though at concentrations below 0.3% by dry weight.4PubMed. Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products
The practical consequence is that full-spectrum CBD products can contain enough THC to show up on a sensitive drug test, even if the amount is far too low to produce any psychoactive effect. Anyone subject to workplace drug screening should know this before choosing a product type. Broad-spectrum and isolate products carry a lower risk on that front, though mislabeling (discussed below) complicates even that assurance.
Extraction From the Plant
Getting CBD out of hemp requires separating the cannabinoid-rich resin from the plant material. Common methods range from industrial-scale supercritical CO₂ extraction to simpler solvent-based approaches. Research comparing straightforward extraction techniques found that using 96% ethanol combined with ultrasound yielded the highest CBD content from hemp flowers, while water extracts produced far less.5PubMed Central. Simple Extraction of Cannabinoids from Female Inflorescences of Hemp (Cannabis sativa L.) The choice of extraction method affects not just how much CBD ends up in the final product but also which other compounds come along for the ride, including residual solvents if the process is poorly controlled.
What the Research Says About CBD’s Effects
CBD has attracted serious clinical interest, particularly for epilepsy. Epidiolex, a pharmaceutical-grade CBD product, is FDA-approved for seizures associated with several rare pediatric epilepsies. In a preliminary study of children with refractory epilepsy, about three-quarters of caregivers reported improvements in both seizure frequency and anxiety after four to six weeks of treatment.6PubMed Central. Preliminary Prospective Study of Pharmaceutical-Grade Cannabidiol for Seizure Frequency, Anxiety, and Comorbid Symptoms in Pediatric Epilepsy: Associations With Circulating Endocannabinoids and Lipid Biomarkers A separate open-label study in patients with refractory epileptic spasms found that a third of participants became spasm-free after two months of CBD treatment.7PubMed. Cannabidiol in treatment of refractory epileptic spasms: An open-label study
Beyond epilepsy, CBD is widely used for anxiety and sleep, though the evidence here is thinner. A case series following 72 adults found that anxiety scores decreased within the first month for about 79% of participants.8PubMed Central. Cannabidiol in Anxiety and Sleep: A Large Case Series Cross-sectional surveys of CBD users report that people who take it for stress, anxiety, and sleep generally perceive it as effective.9PubMed Central. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems The research on dosing, though, is not straightforward. One controlled study of CBD during public speaking found that a 300 mg dose reduced anxiety, but 100 mg and 900 mg did not, suggesting an inverted U-shaped dose-response curve where more is not necessarily better.10PubMed Central. Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Safety Concerns That Often Get Overlooked
CBD’s reputation as a gentle, natural supplement has outpaced the safety data. The most well-documented risk involves the liver. A randomized clinical trial in healthy adults found that about 5.6% of participants receiving CBD experienced liver enzyme elevations more than three times the upper limit of normal, while nobody in the placebo group did.11JAMA Internal Medicine. Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial In a smaller open-label trial using a therapeutic dose of about 1,500 mg per day, nearly a third of healthy volunteers met international criteria for drug-induced liver injury.12PubMed Central. Metabolism and liver toxicity of cannabidiol
A meta-analysis comparing CBD to placebo found that CBD carried roughly six times the odds of liver enzyme elevation and about five times the odds of drug-induced liver injury. High doses and concurrent use of anti-epileptic drugs were identified as risk factors. No cases of severe liver failure were reported, but liver enzyme elevations often resolved only after the CBD dose was reduced or stopped, which means the outcome without intervention is unknown.13PubMed Central. Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review
CBD also interacts with a number of common medications. It inhibits several liver enzymes in the cytochrome P450 family, particularly CYP3A4, CYP2C9, and CYP2C19, which are responsible for metabolizing a wide range of drugs.14PubMed. The Influence of CBD and THC on Hepatic Enzymes of the Human Cytochrome P450 Complex Family: A Systematic Literature Review In practice, this means CBD can increase the blood levels of other medications you are taking, potentially amplifying their effects or side effects. If you take prescription drugs and are considering CBD, this interaction is worth discussing with your doctor.15PubMed Central. Clinical Study to Evaluate Drug Interactions of Cannabidiol with Citalopram and Morphine in Healthy Adults
The Label Accuracy Problem
Even if you know exactly what CBD product you want, you may not be getting what the bottle says. An analysis of 80 commercial CBD products found that only about 54% contained CBD within 10% of the amount claimed on the label. Of the rest, some contained far less CBD than advertised, while others contained substantially more.16PubMed Central. Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim This is not a single-country issue. Testing of commercial CBD oils and e-liquids has revealed similar mislabeling patterns internationally, with some products also showing unexpected traces of THC.17PubMed Central. Not what it seems: analytical validation and label accuracy of commercial CBD oils using HPTLC
This makes the dose-response findings from clinical research hard to apply in real life. If research suggests that 300 mg is the effective dose for anxiety but your product actually contains 200 mg per labeled serving, you are unknowingly underdosing. Products that have been independently tested by a third-party lab, with a certificate of analysis available, are the most reliable way to verify what you are actually consuming.
Industrial Hemp Has Nothing to Do With CBD
A significant portion of the global hemp crop never goes anywhere near CBD extraction. Hemp fiber is used in textiles, building materials, rope, and composites. Hemp seeds go into food products for their protein and fat content. Hemp hurds (the woody inner core of the stalk) are used in construction materials like hempcrete. A life cycle assessment of hemp-based building material estimated that producing one kilogram of hemp hurds sequestered more carbon dioxide than was emitted during its entire cultivation and processing chain.18PubMed Central. Environmental Life Cycle Assessment of a Novel Hemp-Based Building Material
These industrial applications existed for thousands of years before anyone isolated CBD. The confusion arises because the 2018 Farm Bill in the United States legalized hemp partly in recognition of its agricultural and industrial value, but the resulting market boom focused overwhelmingly on CBD products. As a result, many consumers now think of hemp primarily as a source of CBD, when the plant’s utility extends far beyond that single compound.
Hemp as a Soil Cleaner
Hemp’s deep root system and tolerance for contaminated soil make it a candidate for phytoremediation, the use of plants to pull pollutants out of the ground. Research has found that hemp shows strong tolerance and accumulation capacity for heavy metals like cadmium, lead, and arsenic, with most metal uptake concentrated in the roots.19Remediation Journal. Current Knowledge on Phytoremediation Potential of Industrial Hemp (Cannabis sativa L.) for PFAS and Heavy Metal Contaminated Soils Studies growing hemp in sewage sludge have confirmed significant accumulation of zinc, copper, and cadmium, with effective movement of these metals from roots to above-ground parts of the plant.20Journal of Environmental Chemical Engineering. Phytoremediation potential of industrial hemp grown in sewage sludge: Growth performance and environmental impact
This trait has a flip side for CBD consumers. If hemp is grown in contaminated soil, those contaminants can end up in the plant biomass used for extraction.21PubMed Central. Potential of Industrial Hemp for Phytoremediation of Heavy Metals The same property that makes hemp useful for cleaning up polluted land makes sourcing and soil quality critical for anyone producing ingestible hemp products. This is one more reason third-party lab testing matters: a certificate of analysis should cover not just cannabinoid content but also heavy metals and pesticide residues.
CBD for Dogs and Cats
The CBD trend has extended to pets, with hemp-derived CBD treats and oils marketed for anxiety, pain, and seizures in dogs and cats. Early pharmacokinetic research found that hemp-based CBD appeared relatively safe in healthy dogs and cats over a 12-week period, with no concerning changes in blood chemistry. Dogs absorbed CBD substantially better than cats.22PubMed Central. Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats A 28-day safety study in dogs found that repeated CBD administration was well tolerated, though higher doses (around 12 mg per kilogram of body weight per day) caused more gastrointestinal side effects, mainly hypersalivation, and elevated a liver enzyme called alkaline phosphatase.23PubMed. Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs
The veterinary research is still in its early stages. These are small studies in healthy animals, and the long-term effects are not well characterized. The liver enzyme signal in dogs mirrors the hepatotoxicity concern in humans, which suggests that veterinary CBD use deserves the same caution around dosing and monitoring as human use. If you are considering CBD for a pet, a veterinarian familiar with cannabinoid pharmacology is the right person to consult, not the label on a pet-store product.
The Legal Landscape Remains Messy
The legal relationship between hemp and CBD has been a moving target. Before 2018, hemp cultivation was heavily restricted in the United States despite the plant’s long agricultural history. Legal analyses have argued that CBD’s legal status depends on its source: CBD derived from parts of the cannabis plant that fall outside the Controlled Substances Act’s definition of marijuana, from imported non-psychoactive hemp, or from industrial hemp cultivated under a state pilot program could each be considered legal under different frameworks.24PubMed Central. Regulatory Status of Cannabidiol in the United States: A Perspective. The 2018 Farm Bill removed hemp (defined as cannabis with less than 0.3% THC) from the Controlled Substances Act, which opened the floodgates for hemp-derived CBD products. But the FDA has not established a clear regulatory pathway for CBD as a dietary supplement or food additive, which is why the market remains a patchwork of state-level rules and inconsistent enforcement. Some states allow CBD in food and beverages; others prohibit it. The same product can be legal in one state and technically illegal in the next.